International Biotechnology (IBT) Competitors GBX 592 +8.00 (+1.37%) As of 05:01 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock IBT vs. MUT, TFIF, MRCH, NBPE, AGT.LN, JESC, ESCT, SDP, GSCT, and BGSCShould you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include Murray Income Trust (MUT), TwentyFour Income (TFIF), The Merchants Trust (MRCH), NB Private Equity Partners (NBPE), AVI Global Trust (AGT.LN), JPMorgan European Smaller Companies Trust (JESC), The European Smaller Companies Trust (ESCT), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), The Global Smaller Companies Trust (GSCT), and BMO Global Smaller Companies (BGSC). These companies are all part of the "asset management" industry. International Biotechnology vs. Its Competitors Murray Income Trust TwentyFour Income The Merchants Trust NB Private Equity Partners AVI Global Trust JPMorgan European Smaller Companies Trust The European Smaller Companies Trust Schroder Investment Trust - Schroder AsiaPacific Fund The Global Smaller Companies Trust BMO Global Smaller Companies International Biotechnology (LON:IBT) and Murray Income Trust (LON:MUT) are both small-cap financial services companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Do insiders & institutionals hold more shares of IBT or MUT? 45.2% of International Biotechnology shares are held by institutional investors. Comparatively, 35.0% of Murray Income Trust shares are held by institutional investors. 4.2% of International Biotechnology shares are held by company insiders. Comparatively, 3.0% of Murray Income Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer IBT or MUT? In the previous week, Murray Income Trust had 1 more articles in the media than International Biotechnology. MarketBeat recorded 1 mentions for Murray Income Trust and 0 mentions for International Biotechnology. Murray Income Trust's average media sentiment score of 0.51 beat International Biotechnology's score of 0.00 indicating that Murray Income Trust is being referred to more favorably in the news media. Company Overall Sentiment International Biotechnology Neutral Murray Income Trust Positive Is IBT or MUT a better dividend stock? International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.9%. Murray Income Trust pays an annual dividend of GBX 39 per share and has a dividend yield of 4.5%. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. Murray Income Trust pays out 43.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Biotechnology is clearly the better dividend stock, given its higher yield and lower payout ratio. Is IBT or MUT more profitable? Murray Income Trust has a net margin of 92.34% compared to International Biotechnology's net margin of 90.66%. International Biotechnology's return on equity of 13.67% beat Murray Income Trust's return on equity.Company Net Margins Return on Equity Return on Assets International Biotechnology90.66% 13.67% 3.57% Murray Income Trust 92.34%9.57%4.65% Which has more risk and volatility, IBT or MUT? International Biotechnology has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, Murray Income Trust has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Which has stronger valuation & earnings, IBT or MUT? Murray Income Trust has higher revenue and earnings than International Biotechnology. International Biotechnology is trading at a lower price-to-earnings ratio than Murray Income Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInternational Biotechnology£41.82M5.09£37.91M£104.805.65Murray Income Trust£97.96M8.88£90.45M£90.769.59 SummaryMurray Income Trust beats International Biotechnology on 9 of the 15 factors compared between the two stocks. Get International Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBT vs. The Competition Export to ExcelMetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£212.65M£1.24B£6.21B£2.96BDividend Yield4.20%4.37%4.18%5.02%P/E Ratio5.6521.9813.14151.31Price / Sales5.092,372.071,749.08242,297.52Price / Cash155.7460.8149.6227.97Price / Book0.771.221.914.55Net Income£37.91M£263.98M£1.23B£5.90B7 Day Performance1.02%0.41%0.41%1.41%1 Month Performance-2.31%2.67%3.05%4.62%1 Year Performance-7.79%6.62%15.09%79.67% International Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBTInternational BiotechnologyN/AGBX 592+1.4%N/A-7.9%£212.65M£41.82M5.65N/AMUTMurray Income TrustN/AGBX 843-0.4%N/A-0.3%£842.23M£97.96M9.29147,000Positive NewsDividend CutTFIFTwentyFour IncomeN/AGBX 112.40+0.4%N/A+7.2%£841.34M£55.96M0.97N/AMRCHThe Merchants TrustN/AGBX 560-0.2%N/A-2.9%£832.89M£119.93M7.65N/ANBPENB Private Equity PartnersN/AGBX 1,412-0.1%N/A-11.0%£818.97M£12.90M-37.03N/AAGT.LNAVI Global TrustN/AN/AN/AN/A£812.93M£51.62M20.82N/AHigh Trading VolumeJESCJPMorgan European Smaller Companies TrustN/AN/AN/AN/A£795.72M£114.05M7.60N/AESCTThe European Smaller Companies TrustN/AGBX 201+0.5%N/A+15.5%£792.82M£96.24M9.48305Positive NewsGap DownSDPSchroder Investment Trust - Schroder AsiaPacific FundN/AGBX 548flatN/A+3.7%£774.14M£134.70M6.39N/ANews CoverageGSCTThe Global Smaller Companies TrustN/AGBX 160.80+0.4%N/A-0.2%£773.01M£70.77M1.30N/APositive NewsEarnings ReportBGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/A Related Companies and Tools Related Companies Murray Income Trust Competitors TwentyFour Income Competitors The Merchants Trust Competitors NB Private Equity Partners Competitors AVI Global Trust Competitors JPMorgan European Smaller Companies Trust Competitors The European Smaller Companies Trust Competitors Schroder Investment Trust - Schroder AsiaPacific Fund Competitors The Global Smaller Companies Trust Competitors BMO Global Smaller Companies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IBT) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding International Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share International Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
